{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:21:53Z","timestamp":1784042513678,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jceh.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,23]],"date-time":"2016-01-23T02:29:31Z","timestamp":1453516171000},"page":"175-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study"],"prefix":"10.1016","volume":"6","author":[{"given":"Vijendra","family":"Kirnake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romesh","family":"Chawlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"December (6)","key":"10.1016\/j.jceh.2016.01.004_bib0170","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1478-3231.2005.01163.x","article-title":"Portal hypertension: from pathophysiology to clinical practice","volume":"25","author":"Laleman","year":"2005","journal-title":"Liver Int"},{"issue":"June (6)","key":"10.1016\/j.jceh.2016.01.004_bib0175","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/hep.23689","article-title":"Carvedilol for portal hypertension in patients with cirrhosis","volume":"51","author":"Bosch","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jceh.2016.01.004_bib0180","first-page":"20","article-title":"Beta-blockers in liver cirrhosis","volume":"27","author":"Giannelli","year":"2014","journal-title":"Ann Gastroenterol"},{"issue":"February (2)","key":"10.1016\/j.jceh.2016.01.004_bib0185","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/hep.20061","article-title":"Targeting portal pressure measurements: a critical reappraisal","volume":"39","author":"Thalheimer","year":"2004","journal-title":"Hepatology"},{"issue":"August (8)","key":"10.1016\/j.jceh.2016.01.004_bib0190","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1572-0241.2000.02266.x","article-title":"Propranolol in primary and secondary prophylaxis of variceal bleeding among cirrhotics in India: a hemodynamic evaluation","volume":"95","author":"De","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"November (5)","key":"10.1016\/j.jceh.2016.01.004_bib0195","first-page":"1082","article-title":"Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis","volume":"18","author":"Feu","year":"1993","journal-title":"Hepatology"},{"issue":"August (6)","key":"10.1016\/j.jceh.2016.01.004_bib0200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3109\/00365528809093934","article-title":"Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosis","volume":"23","author":"Braillon","year":"1988","journal-title":"Scand J Gastroenterol"},{"issue":"December (12)","key":"10.1016\/j.jceh.2016.01.004_bib0205","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/BF01299807","article-title":"Hemodynamic effect of propranolol on portal hypertension in patients with HBsAg-positive cirrhosis","volume":"31","author":"Kong","year":"1986","journal-title":"Dig Dis Sci"},{"issue":"July (1)","key":"10.1016\/j.jceh.2016.01.004_bib0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding","volume":"137","author":"Villanueva","year":"2009","journal-title":"Gastroenterology"},{"issue":"May (1\u20132)","key":"10.1016\/j.jceh.2016.01.004_bib0215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0168-8278(92)90044-P","article-title":"Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990","volume":"15","author":"De Franchis","year":"1992","journal-title":"J Hepatol"},{"issue":"February (2)","key":"10.1016\/j.jceh.2016.01.004_bib0220","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"issue":"April (2)","key":"10.1016\/j.jceh.2016.01.004_bib0225","first-page":"74","article-title":"Hepatic venous pressure gradient measurement: time to learn!","volume":"27","author":"Kumar","year":"2008","journal-title":"Indian J Gastroenterol"},{"issue":"February (2)","key":"10.1016\/j.jceh.2016.01.004_bib0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1440-1746.2002.02674.x","article-title":"Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics","volume":"17","author":"De","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"June (2)","key":"10.1016\/j.jceh.2016.01.004_bib0235","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1665-2681(19)32023-X","article-title":"Beta blockers in portal hypertension. Are they really a good option?","volume":"5","author":"L\u00f3pez-M\u00e9ndez","year":"2006","journal-title":"Ann Hepatol"},{"issue":"August (4)","key":"10.1016\/j.jceh.2016.01.004_bib0240","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1665-2681(19)30849-X","article-title":"Hemodynamic effect of carvedilol vs. propranolol in cirrhotic patients: systematic review and meta-analysis","volume":"13","author":"Aguilar-Olivos","year":"2014","journal-title":"Ann Hepatol"},{"issue":"March (6)","key":"10.1016\/j.jceh.2016.01.004_bib0245","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"May (5)","key":"10.1016\/j.jceh.2016.01.004_bib0250","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/liv.12360","article-title":"Beta-blockers in portal hypertension: new developments and controversies","volume":"34","author":"Tripathi","year":"2014","journal-title":"Liver Int"},{"issue":"May (5)","key":"10.1016\/j.jceh.2016.01.004_bib0255","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/hep.22273","article-title":"Portal hypertension and variceal bleeding \u2013 unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference","volume":"47","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"issue":"August (2)","key":"10.1016\/j.jceh.2016.01.004_bib0260","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2009.04.015","article-title":"Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension","volume":"51","author":"La Mura","year":"2009","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jceh.2016.01.004_bib0265","first-page":"467","article-title":"Acute and 14-day hepatic venous pressure gradient response to carvedilol and nebivolol in patients with liver cirrhosis","volume":"49","author":"Silkauskait\u0117","year":"2013","journal-title":"Medicina (Kaunas)"},{"issue":"October (10)","key":"10.1016\/j.jceh.2016.01.004_bib0270","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/j.1572-0241.2004.40179.x","article-title":"Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis","volume":"99","author":"Lin","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"March (3)","key":"10.1016\/j.jceh.2016.01.004_bib0275","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2036.2002.01190.x","article-title":"Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension","volume":"16","author":"Tripathi","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"March (3)","key":"10.1016\/j.jceh.2016.01.004_bib0280","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0168-8278(99)80108-1","article-title":"Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis","volume":"30","author":"Stanley","year":"1999","journal-title":"J Hepatol"},{"issue":"April (4)","key":"10.1016\/j.jceh.2016.01.004_bib0285","first-page":"353","article-title":"Effects of the alpha-\/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension","volume":"47","author":"Sekiyama","year":"1997","journal-title":"Arzneimittelforschung"},{"issue":"December (6)","key":"10.1016\/j.jceh.2016.01.004_bib0290","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0168-8278(96)80296-0","article-title":"Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis","volume":"25","author":"Forrest","year":"1996","journal-title":"J Hepatol"},{"issue":"April (4)","key":"10.1016\/j.jceh.2016.01.004_bib0295","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/00365521.2012.666673","article-title":"Carvedilol or propranolol in portal hypertension? A randomized comparison","volume":"47","author":"Hobolth","year":"2012","journal-title":"Scand J Gastroenterol"},{"issue":"November (5)","key":"10.1016\/j.jceh.2016.01.004_bib0300","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2014.06.015","article-title":"Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding","volume":"61","author":"Stanley","year":"2014","journal-title":"J Hepatol"},{"issue":"August (2)","key":"10.1016\/j.jceh.2016.01.004_bib0305","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/hep.22358","article-title":"Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding","volume":"48","author":"Lo","year":"2008","journal-title":"Hepatology"},{"issue":"October (4)","key":"10.1016\/j.jceh.2016.01.004_bib0310","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"53","author":"De Franchis","year":"2010","journal-title":"J Hepatol"},{"issue":"July (7)","key":"10.1016\/j.jceh.2016.01.004_bib0315","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of \u03b2-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"issue":"March (3)","key":"10.1016\/j.jceh.2016.01.004_bib0320","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jhep.2013.09.016","article-title":"The changing role of beta-blocker therapy in patients with cirrhosis","volume":"60","author":"Ge","year":"2014","journal-title":"J Hepatol"},{"issue":"July (1)","key":"10.1016\/j.jceh.2016.01.004_bib0325","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.510300124","article-title":"Carvedilol, a new nonselective beta-blocker with intrinsic anti-Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis","volume":"30","author":"Ba\u00f1ares","year":"1999","journal-title":"Hepatology"},{"issue":"December (6)","key":"10.1016\/j.jceh.2016.01.004_bib0330","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/hep.1840360612","article-title":"Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis","volume":"36","author":"Ba\u00f1ares","year":"2002","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688316000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688316000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:03:59Z","timestamp":1760853839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688316000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0973688316000116"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2016.01.004","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 INASL.","name":"copyright","label":"Copyright"}]}}